349 related articles for article (PubMed ID: 30610616)
21. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.
Cao C; Zhang T; Zhang D; Xie L; Zou X; Lei L; Wu D; Liu L
Oncogene; 2017 Feb; 36(8):1112-1122. PubMed ID: 27530352
[TBL] [Abstract][Full Text] [Related]
22. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma.
Pea A; Jamieson NB; Braconi C
Hepatology; 2021 Jan; 73 Suppl 1():38-48. PubMed ID: 32160335
[TBL] [Abstract][Full Text] [Related]
23. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
[TBL] [Abstract][Full Text] [Related]
24. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
25. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
[TBL] [Abstract][Full Text] [Related]
26. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA TRPM2-AS as a potential biomarker for hepatocellular carcinoma.
Xu C; Huang Q; Zhang C; Xu W; Xu G; Zhao X; Liu X; Du Y
Ir J Med Sci; 2018 Aug; 187(3):621-628. PubMed ID: 29081064
[TBL] [Abstract][Full Text] [Related]
28. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
[TBL] [Abstract][Full Text] [Related]
29. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
Front Immunol; 2022; 13():985815. PubMed ID: 36300115
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664.
He JH; Han ZP; Liu JM; Zhou JB; Zou MX; Lv YB; Li YG; Cao MR
J Cell Biochem; 2017 Nov; 118(11):3713-3721. PubMed ID: 28374914
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
33. [Advances in the role of exosome-derived long non-coding RNAs in hepatocellular carcinoma].
Zhou C; Wang CJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):77-81. PubMed ID: 30685932
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA colon cancer-associated transcript 1 functions as a competing endogenous RNA to regulate cyclin-dependent kinase 1 expression by sponging miR-490-3p in hepatocellular carcinoma progression.
Dou C; Sun L; Jin X; Han M; Zhang B; Li T
Tumour Biol; 2017 Apr; 39(4):1010428317697572. PubMed ID: 28381168
[TBL] [Abstract][Full Text] [Related]
35. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
El Khodiry A; Afify M; El Tayebi HM
World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
38. Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications.
Shi Q; Chu Q; Zeng Y; Yuan X; Wang J; Zhang Y; Xue C; Li L
Cell Commun Signal; 2023 Dec; 21(1):359. PubMed ID: 38111040
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNAs in liver cancer: what we know in 2014.
Zhao J; Greene CM; Gray SG; Lawless MW
Expert Opin Ther Targets; 2014 Oct; 18(10):1207-18. PubMed ID: 25145388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
